SCHEMBL5110128

SCHEMBL5110128

CC(C)C(=O)Nc1cc(F)cc(COc2c(Cl)cc(C(=O)NCC(=O)O)cc2Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SENP5 Q96HI0 1/20 0.40
SENP2 Q9HC62 1/20 0.40
SENP1 Q9P0U3 1/20 0.40
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
PTGER1 P34995 1/20 0.37
GPR139 Q6DWJ6 1/20 0.37
ALDH1A1 P00352 4/20 0.36
HPGD P15428 3/20 0.36
RAB9A P51151 2/20 0.36
GAA P10253 2/20 0.36
LMNA P02545 2/20 0.36
NPC1 O15118 1/20 0.36
ABL1 P00519 1/20 0.36
MAPT P10636 1/20 0.36
RIN1 Q13671 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PLAU P00749 2/20 0.36
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5722494 0.95 THRA (0.42) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL5111314 0.90 SENP5 (0.40) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL5104457 0.90 SENP5 (0.41) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL5117805 0.89 SENP5 (0.40) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL5105172 0.89 BRD4 (0.39) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL4928440 0.89 GPR139 (0.39) MEN1KMT2AGPR139ALDH1A1HPGD
SCHEMBL5118577 0.87 SCN9A (0.41) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL5722496 0.87 SENP5 (0.35) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL5111320 0.87 ALDH1A1 (0.39) SENP5SENP2SENP1MEN1KMT2A
SCHEMBL4932562 0.86 ALDH1A1 (0.39) MEN1KMT2AGPR139ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA SENP5 2379/4885SENP2 4509/4885SENP1 4088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.